or
forgot password
  • cancer clinical trials in lubbock, TX

  • S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Adrenocortical Carcinoma
    Combination Chemotherapy in Treating Children With Progressive Brain Tumors
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Brain and Central Nervous System Tumors
    S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Lung Cancer
    Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
    Covenant Health System
    Lubbock, Texas 79410
    Endometrial Cancer
    S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Pancreatic Cancer
    Combination Chemotherapy in Treating Children With Neuroblastoma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Neuroblastoma
    Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Breast Cancer
    Surgery in Treating Children With Neuroblastoma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Neuroblastoma
    S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Endometrial Cancer
    Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Brain Tumors, Central Nervous System Tumors, Neuroblastoma, Sarcoma
    S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Lung Cancer
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Leukemia
    Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Pancreatic Cancer
    Vinorelbine in Treating Children With Recurrent or Refractory Cancers
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma
    SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Colorectal Cancer
    Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Lung Cancer
    Brachytherapy in Treating Patients With Prostate Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Prostate Cancer
    S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Cervical Cancer
    Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Brain and Central Nervous System Tumors
    Combination Chemotherapy in Treating Women With Breast Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Breast Cancer
    506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Leukemia, Lymphoma
    S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Neuroendocrine Carcinoma of the Skin
    S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Lung Cancer
    Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Anal Cancer
    S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Malignant Mesothelioma
    Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Sarcoma
    S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Bladder Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Diarrhea, Radiation Enteritis
    S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Melanoma (Skin)
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Joe Arrington Cancer Research and Treatment Center

    Trial Locations
    Joe Arrington Cancer Research and Treatment Center
    Southwest Cancer and Research Center at University Medical Center
    Breast Cancer
    S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Lung Cancer
    S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Lung Cancer
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Anemia, Head and Neck Cancer
    Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Head and Neck Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Head and Neck Cancer
    S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Multiple Myeloma
    S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
    Texas Tech University Health Science Center

    Trial Locations
    Texas Tech University Health Science Center
    Health Science Center
    Leukemia, Myelodysplastic Syndromes
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Prostate Cancer
    Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Colorectal Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Brain and Central Nervous System Tumors
    Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Lung Cancer
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Lung Cancer
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Liver Cancer
    S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Kidney Cancer
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Brain and Central Nervous System Tumors
    Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
    Southwest Cancer and Research Center at University Medical Center
    Lubbock, Texas 79415-3364
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Lung Cancer